Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL29922103

NCCCCCCNC(=O)c1ccc2c(c1)C(=O)N(C1CCC(=O)NC1=O)C2=O.O=C(O)C(F)(F)F

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 16/20 0.64
DDB1 Q16531 12/20 0.64
BRD4 O60885 1/20 0.48
CA2 P00918 2/20 0.48
HDAC8 Q9BY41 1/20 0.46
STAT3 P40763 2/20 0.45
HDAC3 O15379 2/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC2 Q92769 2/20 0.45
NCOR2 Q9Y618 2/20 0.45
HDAC4 P56524 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
ALDH1A1 P00352 1/20 0.44
CHRM2 P08172 1/20 0.44
OPRM1 P35372 1/20 0.44
IKZF3 Q9UKT9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL17839978 1.00 CRBN (0.64) CRBNDDB1BRD4CA2HDAC8
SCHEMBL17839882 0.94 CRBN (0.68) CRBNDDB1BRD4CA2HDAC8
SCHEMBL29922205 0.94 CRBN (0.68) CRBNDDB1BRD4CA2HDAC8
SCHEMBL17854847 0.88 CRBN (0.65) CRBNDDB1BRD4CA2HDAC8
SCHEMBL20188342 0.88 CRBN (0.72) CRBNDDB1BRD4HDAC8STAT3
SCHEMBL17839575 0.88 CRBN (0.72) CRBNDDB1BRD4HDAC8STAT3
Trifluoroacetic Acid SCHEMBL19747583 0.87 CRBN (0.63) CRBNDDB1STAT3
Trifluoroacetic Acid SCHEMBL19747894 0.87 CRBN (0.63) CRBNDDB1STAT3
Trifluoroacetic Acid SCHEMBL29493530 0.87 CRBN (0.63) CRBNDDB1STAT3
Trifluoroacetic Acid SCHEMBL29493526 0.87 CRBN (0.63) CRBNDDB1STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108350062-B Targeted protein degradation to attenuate adverse inflammatory responses associated with adoptive T cell therapy 达纳-法伯癌症研究所股份有限公司 2022-10-14 CN disclosed